Data / Form D filings / Smisson-Cartledge Biomedical, LLC
Smisson-Cartledge Biomedical, LLC: Form D filings
Smisson-Cartledge Biomedical, LLC, a biotechnology company in Macon, GA, filed 4 Form D notices with the SEC between 2010 and 2012. The latest, on July 27, 2012, reports $2 million sold of a $2 million offering to 1 investor.
Find out what Smisson-Cartledge Biomedical, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 487 CHERRY STREET, 3RD FLOOR, Macon, GA, 31201
- Phone
- (478) 744-9992
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Georgia
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1507992
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27, 2012 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | Jul 10, 2012 | sec.gov |
| May 21, 2012 | New notice | $1,000,000 | $1,000,000 | $0 | 1 | Apr 16, 2012 | sec.gov |
| Nov 16, 2011 | New notice | $700,003 | $316,595 | $383,408 | 8 | Oct 12, 2011 | sec.gov |
| Dec 16, 2010 | New notice | $1,007,547 | $116,397 | $891,150 | 12 | Dec 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard G. Cartledge, M.D. | Executive Officer, Director, Promoter | |
| David C. Field | Executive Officer, Director, Promoter | |
| Calder B. Clay III | Executive Officer, Director, Promoter | |
| Christopher T. Collins | Director, Promoter | |
| Thomas W. Glasgow, Jr. | Director | |
| Steve T. Zenezak | Director | |
| Hugh F. Smisson III, M.D. | Executive Officer, Director, Promoter |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Jul 23, 2012 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Smisson-Cartledge Biomedical, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.